Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Womb (uterine or endometrial) cancer
Closed
Phase 3
This trial is comparing a drug called ixabepilone with either paclitaxel or doxorubicin for womb cancer that has come back or spread to another part of the body after treatment with chemotherapy.
Recruitment start: 9 December 2009
Recruitment end: 13 January 2012
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Prof Nick Reed
Bristol-Myers Squibb
Experimental Cancer Medicine Centre (ECMC)
Last reviewed: 22 Sept 2014
CRUK internal database number: 4374